Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Inebilizumab for Treatment of IgG4-Related Disease.

Journal article

Stone JH. et al, (2024), The New England journal of medicine

Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment.

Journal article

Overbeek KA. et al, (2024), Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 22, 994 - 1004.e10

Challenges and pitfalls in the diagnosis of IgG4-related disease.

Journal article

Bateman AC. and Culver EL., (2024), Seminars in diagnostic pathology, 41, 45 - 53

Fibrotic phenotype of IgG4-related disease.

Journal article

Lanzillotta M. et al, (2024), The Lancet. Rheumatology

IgG4-related disease

Journal article

Nwaduru C. and Culver EL., (2023), Medicine (United Kingdom), 51, 405 - 411

UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis.

Journal article

Abbas N. et al, (2023), Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 21, 1561 - 1570.e13

Development of an algorithm for IgG4-related disease management.

Journal article

Orozco-Gálvez O. et al, (2023), Autoimmunity reviews, 22

Evaluation of Tofacitinib in Primary Sclerosing Cholangitis and Associated Colitis: A Multicenter, Retrospective Study.

Other

Schregel I. et al, (2023), Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Load More